Intranasal Delivery of Soluble OVA and Apoptotic Cells
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : National Jewish Health, University of Colorado Denver, University of Colorado Anschutz Medical Campus
Variable analysis
- Delivery of soluble OVA (sOVA)
- Delivery of apoptotic cells
- Delivery of TLR agonists (R848 and Poly I:C)
- Measured outcomes (not explicitly mentioned)
- Anesthesia (avertin with tert-amyl alcohol and 2,2,2 tribromoethanol)
- Volume of deliveries (50 μl)
- Soluble OVA (sOVA) at 1 μg
- Apoptotic cells without TLR agonists
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!